Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 28
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Maternal-infant antibiotic resistance genes transference: what do we know?

  • Samarra, Anna
  • Esteban Torres, María
  • Cabrera-Rubio, Raúl
  • Bernabeu, Manuel
  • Arboleya, Silvia
  • Gueimonde Fernández, Miguel
  • Collado, María Carmen
Resistance to antibiotics is becoming a worldwide threat as infections caused by multidrug-resistant pathogenic microorganisms can overcome antibiotic treatments and spread quickly in the population. In the context of early life, newborns are at increased risk as their immune system is still under development, so infections and acquisition of resistance during childhood have short- and long-term consequences for the health. The moment of birth is the first exposure of infants to possible antibiotic-resistant microorganisms that may colonize their gut and other body sites. Different factors including mode of delivery, previous antibiotic exposure of the mother, gestational age and consumption of antibiotics in early-life have been described to modulate the neonate's microbiota, and thus, the resistome. Other factors, such as lactation, also impact the establishment and development of gut microbiota, but little is known about the role of breastmilk in transferring Antibiotic Resistant Genes (ARG). A deeper understanding of vertical transmission of antibiotic resistance from mothers to their offspring is necessary to determine the most effective strategies for reducing antibiotic resistance in the early life. In this review, we aim to present the current perspective on antibiotic resistances in mother-infant dyads, as well as a new insight on the study of the human gut and breastmilk resistome, and current strategies to overcome this public health problem, toward highlighting the gaps of knowledge that still need to be closed., We acknowledge Generalitat Valenciana-European Social Fund (ACIF/2021) for the predoctoral fellowship grant to Anna Samarra. Manuel Bernabeu wishes to thank the Post-PhD Program of University of Barcelona for the requalification of the Spanish University System from the Ministry of Universities of the Government of Spain, modality “Margarita Salas”, financed by the European Union, Next Generation EU. Maria Esteban-Torres thanks the support received from the MSCA-IF postdoctoral grant (MicroMi-898088). Raul Cabrera-Rubio wishes to thank Generalitat-Valenciana for the grant Plan GenT project (CDEIGENT 2020). Finally, authors also acknowledge support of Institute of Agrochemistry and Food Technology (IATA-CSIC). IATA-CSIC is a Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microbiome Interconnectedness throughout Environments with Major Consequences for Healthy People and a Healthy Planet

  • Sessitsch, Angela
  • Wakelin, Steve
  • Schloter, Michael
  • Maguin, Emmanuelle
  • Cernava, Tomislav
  • Champomier-Verges, Marie-Christine
  • Charles, Trevor C
  • Cotter, Paul D
  • Ferrocino, Ilario
  • Kriaa, Aicha
  • Lebre, Pedro
  • Cowan, Don
  • Lange, Lene
  • Kiran, Seghal
  • Markiewicz, Lidia
  • Meisner, Annelein
  • Olivares, Marta
  • Sarand, Inga
  • Schelkle, Bettina
  • Selvin, Joseph
  • Smidt, Hauke
  • van Overbeek, Leo
  • Berg, Gabriele
  • Cocolin, Luca
  • Sanz Herranz, Yolanda
  • Fernandes, Wilson Lemos
  • Liu, S J
  • Ryan, Matthew
  • Singh, Brajesh
  • Kostic, Tanja
Microbiomes have highly important roles for ecosystem functioning and carry out key functions that support planetary health, including nutrient cycling, climate regulation, and water filtration. Microbiomes are also intimately associated with complex multicellular organisms such as humans, other animals, plants, and insects and perform crucial roles for the health of their hosts. Although we are starting to understand that microbiomes in different systems are interconnected, there is still a poor understanding of microbiome transfer and connectivity. In this review we show how microbiomes are connected within and transferred between different habitats and discuss the functional consequences of these connections. Microbiome transfer occurs between and within abiotic (e.g., air, soil, and water) and biotic environments, and can either be mediated through different vectors (e.g., insects or food) or direct interactions. Such transfer processes may also include the transmission of pathogens or antibiotic resistance genes. However, here, we highlight the fact that microbiome transmission can have positive effects on planetary and human health, where transmitted microorganisms potentially providing novel functions may be important for the adaptation of ecosystems., All authors have received funding from the European Union’s H2020 Research and Innovation Program under grant no. 818116 (MicrobiomeSupport). The grant of the Spanish Ministry of Science and Innovation (MCIN/AEI) to IATA-CSIC as Accredited Research Center of Excellence (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033) is acknowledged., With funding from the Spanish government through the‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut Microbial Sialidases and Their Role in the Metabolism of Human Milk Sialylated Glycans

  • Muñoz-Provencio, Diego
  • Yebra, María Jesús
Sialic acids (SAs) are α-keto-acid sugars with a nine-carbon backbone present at the non-reducing end of human milk oligosaccharides and the glycan moiety of glycoconjugates. SAs displayed on cell surfaces participate in the regulation of many physiologically important cellular and molecular processes, including signaling and adhesion. Additionally, sialyl-oligosaccharides from human milk act as prebiotics in the colon by promoting the settling and proliferation of specific bacteria with SA metabolism capabilities. Sialidases are glycosyl hydrolases that release α-2,3-, α-2,6- and α-2,8-glycosidic linkages of terminal SA residues from oligosaccharides, glycoproteins and glycolipids. The research on sialidases has been traditionally focused on pathogenic microorganisms, where these enzymes are considered virulence factors. There is now a growing interest in sialidases from commensal and probiotic bacteria and their potential transglycosylation activity for the production of functional mimics of human milk oligosaccharides to complement infant formulas. This review provides an overview of exo-alpha-sialidases of bacteria present in the human gastrointestinal tract and some insights into their biological role and biotechnological applications., This work was funded by the Spanish Ministry of Science and Innovation (MICIN)/Spanish State Research Agency (AEI)/10.13039/501100011033 Project grant PID2020-115403RB-C21. The study was also supported by Valencian Government grant AICO/2021/033. IATA-CSIC is a Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Overview of alginate extraction processes: Impact on alginate molecular structure and techno-functional properties

  • Bojorges, Hylenne
  • López-Rubio, Amparo
  • Martínez-Abad, Antonio
  • Fabra, María José
Background: Brown algae are a valuable source of various biopolymers, with alginate standing out as a phycocolloid of great industrial importance. Although the extraction process is well established on an industrial scale, several innovative and environmentally friendly extraction technologies have been explored to improve the efficiency of the process both in terms of yields and energy and solvent consumption. Scope and approach: The review aims to describe and analyze different strategies used to extract alginate from brown algae, including different pre-treatment methods used before extraction. In addition, the impact of these extraction technologies, with or without pre-treatments, on alginate's structural and techno-functional properties is also discussed. Key findings: The extraction process parameters play a key role and significantly influence the quality of alginate and the extraction yield. Innovative technologies have the potential to enhance extraction capacity, improve process efficiency, and promote environmental friendliness. Research efforts are focused on achieving sustainable alginate production and co-production of other value-added products. This review provides useful information to the alginate industry towards a more sustainable approach and foster the diversification of high-value products., The authors wish to acknowledge funds from the project PID2020-117744RJ-I00 and grant CEX2021-001189-S funded by MCIN/AEI/10.13039/501100011033 and the project CIRCALGAE (Horizon Europe) under grant agreement 101060607. H. Bojorges acknowledges financial support from the Generalitat Valenciana for the award of a Santiago Grisolía grant (GRISOLIAP/2019/007)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The maternal gut microbiome in pregnancy: implications for the developing immune system

  • Koren, Omry
  • Konnikova, Liza
  • Brodin, Petter
  • Mysorekar, Indira U.
  • Collado, María Carmen
The gut microbiome has important roles in host metabolism and immunity, and microbial dysbiosis affects human physiology and health. Maternal immunity and microbial metabolites during pregnancy, microbial transfer during birth, and transfer of immune factors, microorganisms and metabolites via breastfeeding provide critical sources of early-life microbial and immune training, with important consequences for human health. Only a few studies have directly examined the interactions between the gut microbiome and the immune system during pregnancy, and the subsequent effect on offspring development. In this Review, we aim to describe how the maternal microbiome shapes overall pregnancy-associated maternal, fetal and early neonatal immune systems, focusing on the existing evidence and highlighting current gaps to promote further research., O.K. is supported by the European Research Council Consolidator grant (grant agreement no. 101001355). I.U.M. is supported by NIH/NICHD grant R01 HD091218 and 3R01HD091218-04S1(RADx-UP Supplement). O.K. and M.C.C. acknowledge the support by Biostime Institute Nutrition and Care (BINC) grant. L.K. is supported by Yale University pilot funds, Binational Science Foundation (2019075), and the National Institutes of Health (R21TR002639, R21HD102565, R01DK129552 and R01AI171980). P.B. is supported by grants from Knut and Alice Wallenberg Foundation (2019.0181), Svenska sällskapet för Medicinsk forskning, SSMF (CG-22-0148-H-02), the Swedish Research council (2019-01495, 2022-01567), EU Horizon project grant UNDINE (grant agreement: 101057100) and Wellcome Trust Discovery award (226507/Z/22/Z). M.C.C. was supported by a European Research Council Starting grant (grant agreement no. 639226), the Spanish Ministry of Science and Innovation (grant ref. PID2022-139475OB-I00), PROMETEO GVA (ref. 2020/012) and also from the Horizon Europe Program (INITIALISE- 101094099 project)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of vertical and horizontal microbial transmission of antimicrobial resistance genes in early life: insights from maternal-infant dyads

  • Bernabeu, Manuel
  • Cabello Yeves, Elena
  • Flores, Eduard
  • Samarra, Anna
  • Kimberley Summers, Joanna
  • Marina, Alberto
  • Collado, María Carmen
Early life represents a critical window for metabolic, cognitive and immune system development, which is influenced by the maternal microbiome as well as the infant gut microbiome. Antibiotic exposure, mode of delivery and breastfeeding practices modulate the gut microbiome and the reservoir of antibiotic resistance genes (ARGs). Vertical and horizontal microbial gene transfer during early life and the mechanisms behind these transfers are being uncovered. In this review, we aim to provide an overview of the current knowledge on the transfer of antibiotic resistance in the mother-infant dyad through vertical and horizontal transmission and to highlight the main gaps and challenges in this area., This work has been supported by PROMETEO GVA (NEOHEALTH ref. 2020/012). The authors acknowledge the comments and suggestions of Dr. Raul Cabrera-Rubio. who thanks the Generalitat-Valenciana for the grant of the Plan GenT project (CDEIGENT 2020). M.B. thanks to the post-PhD grant 'Juan de la Cierva' (ref. JDC2022-050269-I) supported by the Spanish Ministry of Science, Innovation and Universities/State Investigation Agency (MCIU/AEI) and the European Union 'NextGenerationEU'/PRTR. E.C-Y received a FPI predoctoral fellowship from the Spanish Ministry of Science and Innovation with identifier PRE2020-092531. E.F.V thanks to a Predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for the training of doctors within the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023 (ref. CEX2021-001189-S-20-1). A.S. acknowledges Generalitat-Valenciana-European Social Fund (ACIF/2021) for the predoctoral fellowship grant. M.C.C. acknowledges the support by the European Research Council Starting grant (MAMI grant ref. 639226), Horizon Europe Program (INITIALISE ref. 101094099), Spanish Ministry of Science and Innovation (MAMI-Plus ref. PID2022-139475OB-I00), by the Joint Action 'European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)' — FOOD-HYPERSENS call (ECOBIOTIC) and the national funding from Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A), Spanish Government (Ministry of Science, Innovation and Universities) and also by Biostime Institute Nutrition & Care (BINC) grant. IATA-CSIC authors also acknowledge the Spanish government Ministry of Science and Innovation/State Investigation Agency (MCIN/AEI) to the Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). A.M. acknowledges the support by grants PID2019-108541GB-I00 and PID2022-137201NB-I00 from Spanish Government (Ministry of Science and Innovation). M.C.C. and A.M. are part of the CSIC's Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hygiene-based measures for the prevention of cytomegalovirus infection in pregnant women: a systematic review

  • Rodríguez-Muñoz, María F.
  • Martín-Martín, Clara
  • Kovacheva, Katina
  • Olivares, María Eugenia
  • Izquierdo, Nuria
  • Pérez-Romero, Pilar
  • García-Ríos, Estéfani
Human Cytomegalovirus (HCMV) is the most frequent congenital infection worldwide causing important sequelae. However, no vaccine or antiviral treatments are currently available, thus interventions are restricted to behavioral measures. The aim of this systematic review was to assess evidence from available intervention studies using hygiene-based measures to prevent HCMV infection during pregnancy., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This study was supported by “Convocatoria IMIENS de ayudas para la realización de Proyectos de Iniciación a la Investigación 2022” awarded to E.G-R and M.R-M. E.G-R. is supported by the Sara Borrell Program (CD18CIII/00007), Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades and the Generalitat Valenciana plan GenT grant No. CIDEIG/2022/028. C.M-M. is supported by the PFIS Program (FI22CIII/0029), Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades. The accreditation to the IATA-CSIC as center of Excellence Severo Ochoa CEX2021-001189-S funded by MCIU/https://doi.org/10.13039/501100011033 is also fully acknowledged., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fighting pathogenic yeasts with plant defensins and anti-fungal proteins from fungi

  • Manzanares, Paloma
  • Giner-Llorca, Moisés
  • Marcos López, José Francisco
  • Garrigues, Sandra
Fungal infections represent a significant health risk worldwide. Opportunistic infections caused by yeasts, particularly by Candida spp. and their virulent emerging isolates, have become a major threat to humans, with an increase in fatal cases of infections attributed to the lack of effective anti-yeast therapies and the emergence of fungal resistance to the currently applied drugs. In this regard, the need for novel anti-fungal agents with modes of action different from those currently available is undeniable. Anti-microbial peptides (AMPs) are promising candidates for the development of novel anti-fungal biomolecules to be applied in clinic. A class of AMPs that is of particular interest is the small cysteine-rich proteins (CRPs). Among CRPs, plant defensins and anti-fungal proteins (AFPs) of fungal origin constitute two of the largest and most promising groups of CRPs showing anti-fungal properties, including activity against multi-resistant pathogenic yeasts. In this review, we update and compare the sequence, structure, and properties of plant defensins and AFPs with anti-yeast activity, along with their in vitro and in vivo potency. We focus on the current knowledge about their mechanism of action that may lead the way to new anti-fungals, as well as on the developments for their effective biotechnological production. KEY POINTS: • Plant defensins and fungal AFPs are alternative anti-yeast agents • Their multi-faceted mode of action makes occurrence of resistance rather improbable • Safe and cost-effective biofactories remain crucial for clinical application., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by grant PID2021-125858OB-100 and the Severo Ochoa Excellence Program CEX2021-001189-S funded by MCIN/AEI/ https://doi.org/10.13039/501100011033 and by “ERDF: A way of making Europe.” This study forms part of the AGROALNEXT program and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. S. G. holds a Juan de la Cierva Incorporación grant (IJC2020-042749-I) funded by MCIN/AEI/ https://doi.org/10.13039/501100011033, “ERDF: A way of making Europe” and ‘NextGenerationEU/PRTR.’ M. G. L. was a recipient of a predoctoral grant FPU19/02066 funded by MCIN/AEI/ https://doi.org/10.13039/501100011033 and by “ESF: Investing in your future.”, With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antiviral Activity of Natural Compounds for Food Safety

  • Falcó, Irene
  • Randazzo, Walter
  • Sánchez Moragas, Gloria
Gastroenteritis and hepatitis are the most common illnesses resulting from the consumption of food contaminated with human enteric viruses. Several natural compounds have demonstrated antiviral activity against human enteric viruses, such as human norovirus and hepatitis A virus, while little information is available for hepatitis E virus. Many in-vitro studies have evaluated the efficacy of different natural compounds against human enteric viruses or their surrogates. However, only few studies have investigated their antiviral activity in food applications. Among them, green tea extract, grape seed extract and carrageenans have been extensively investigated as antiviral natural compounds to improve food safety. Indeed, these extracts have been studied as sanitizers on food-contact surfaces, in produce washing solutions, as active fractions in antiviral food-packaging materials, and in edible coatings. The most innovative applications of these antiviral natural extracts include the development of coatings to extend the shelf life of berries or their combination with established food technologies for improved processes. This review summarizes existing knowledge in the underexplored field of natural compounds for enhancing the safety of viral-contaminated foods and underscores the research needs to be covered in the near future., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The Accreditation as Center of Excellence Severo Ochoa CEX2021-001189-S funded by MCIN/AEI / https://doi.org/10.13039/501100011033 is fully acknowledged. IF is supported by a postdoctoral contract grant for the requalification of the Spanish university system from the Ministry of Universities of the Government of Spain, financed by the European Union (NextGeneration EU) (MS21-006). This research was supported by “PREVISION” (PID2019-105509RJ-I00, MCIN/AEI/https://doi.org/10.13039/501100011033) project funded to WR., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum

  • Byndloss, Mariana
  • Devkota, Suzanne
  • Duca, Frank
  • Niess, Jan Hendrik
  • Nieuwdorp, Max
  • Orho-Melander, Marju
  • Sanz Herranz, Yolanda
  • Tremaroli, Valentina
  • Zhao, Liping
This article summarises the state of the science on the role of the gut microbiota (GM) in diabetes from a recent international expert forum organised by Diabetes, Diabetes Care, and Diabetologia, which was held at the European Association for the Study of Diabetes 2023 Annual Meeting in Hamburg, Germany. Forum participants included clinicians and basic scientists who are leading investigators in the field of the intestinal microbiome and metabolism. Their conclusions were as follows: (1) the GM may be involved in the pathophysiology of type 2 diabetes, as microbially produced metabolites associate both positively and negatively with the disease, and mechanistic links of GM functions (e.g. genes for butyrate production) with glucose metabolism have recently emerged through the use of Mendelian randomisation in humans; (2) the highly individualised nature of the GM poses a major research obstacle, and large cohorts and a deep-sequencing metagenomic approach are required for robust assessments of associations and causation; (3) because single time point sampling misses intraindividual GM dynamics, future studies with repeated measures within individuals are needed; and (4) much future research will be required to determine the applicability of this expanding knowledge to diabetes diagnosis and treatment, and novel technologies and improved computational tools will be important to achieve this goal., The 2023 Diabetes, Diabetes Care, and Diabetologia expert forum ‘The microbiome and diabetes: research, translation and clinical applications’, including a subsequent symposium presented on this topic and the preparation of this article, was supported by a grant from the Novo Nordisk Foundation (NNF23SA0085453). MB is a Howard Hughes Medical Institute Freeman Hrabowski Scholar and is supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant NIDDK R01DK131104, the Pew Charitable Trusts (2022-A-19568), and the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease (022792). SD is supported by NIDDK grants NIDDK R01DK123446 and 1DP1 DK130687. JHN is supported by the Swiss National Science Foundation (SNSF) grant 310030_219210. MN is supported by a personal ZONMW-VICI grant 2020 (09150182010020) and a DFN-DON grant 2020 (2020.10.002). YS is supported by grants from the Spanish Ministry of Science, Innovation and Universities MICIU/AEI (PID2020-119536RB-I00) and Severo Ochoa Center of Excellence (ref. CEX2021- 001189-S/10.13039/501100011033). VT is a co-principal investigator of a research project funded by the European Union’s Innovative Medicines Initiative (IMI grant 875534)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mind the gap regarding the knowledge of infant exposure to mycotoxins, acrylamide, bisphenols and heavy metals through human milk

  • Pallarés, Noelia
  • Ferrer, Emilia
  • Berrada, Houda
  • Barba, Francisco J.
  • Salgado-Ramos, Manuel
  • Collado, María Carmen
Breastfeeding offers infants nutritional, immunological, neurological and emotional benefits, although some toxic compounds can also be detected in human milk and transported along this food chain, such as mycotoxins, bisphenols, heavy metals, and acrylamide. This narrative review collects data from around the world regarding the occurrence of these contaminants in human milk with a view to evaluate infant exposure to these compounds and the potential associated health risks. The factors driving the presence of these toxins in human milk are explored, as are some strategies and measures to minimize their transfer to infants. The incidence and the levels of toxic compounds reported in bibliography vary, ranging from trace levels to considerably high concentrations. The data obtained suggest that breastfed infants better tolerate exposure to toxic compounds than infants fed with milk formulas, even though in some cases the estimated daily intake may exceed the established reference values. Certain measures should be adopted to minimize the exposure of mothers and breastfed infants to toxic compounds, such as monitoring of good practices throughout the food chain and dietary control, avoiding commodities more susceptible to contamination., This preparation of this review was supported by the Spanish Ministry of Science and Innovation project (PID2020-115871RB-I00) and by the Generalitat Valenciana (Spain: projects GV/2020/020 and AICO/2021/037). N.P. was supported by the post-PhD program of the University of Valencia for the requalification of the Spanish University System from the Ministry of Universities of the Government of Spain, modality “Margarita Salas” (MS21-045)”, financed by the European Union, Next Generation EU. M.S–R was supported by the post-PhD program from the Universidad de Castilla-La Mancha and by the Ministry of Universities of the Spanish Government, modality “Margarita Salas - Complementaria” (2023-POST-21234), financed by the European Union, Next Generation EU. Finally, M.C.C. acknowledges the support of The Ramón Areces Foundation (ref. CIVP19A5918) and also, the award of the Spanish government MCIN/AEI to the IATA-CSIC as Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). M.C.C. also acknowledges the support of an H2020-ERC Starting Grant 639226 and that of the Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime

  • Medina Rodríguez, Eva M.
  • Martínez Raga, José
  • Sanz Herranz, Yolanda
Depression is a highly prevalent disorder and a leading cause of disability worldwide. It has a major impact on the affected individual and on society as a whole. Regrettably, current available treatments for this condition are insufficient in many patients. In recent years, the gut microbiome has emerged as a promising alternative target for treating and preventing depressive disorders. However, the microbes that form this ecosystem do not act alone but are part of a complicated network connecting the gut and the brain that influences our mood. Host cells that are in intimate contact with gut microbes, such as the epithelial cells forming the gut barrier and the immune cells in their vicinity, play a key role in the process. These cells continuously shape immune responses to maintain healthy communication between gut microbes and the host. In this article, we review how the interplay among epithelial cells, the immune system, and gut microbes mediates gut-brain communication to influence mood. We also discuss how advances in our knowledge of the mechanisms underlying the gut-brain axis could contribute to addressing depression. SIGNIFICANCE STATEMENT: This review does not aim to systematically describe intestinal microbes that might be beneficial or detrimental for depression. We have adopted a novel point of view by focusing on potential mechanisms underlying the crosstalk between gut microbes and their intestinal environment to control mood. These pathways could be targeted by well defined and individually tailored dietary interventions, microbes, or microbial metabolites to ameliorate depression and decrease its important social and economic impact., This work was funded by the Spanish State Research Agency (AEI, Spain) [Grant PID2022-142106OA-I00] and the Miguel Servet program from Carlos III Health Institute (ISCIII, Spain) [Grant CP22/00030], cofunded by the European Union, and supported by the EarlyCause Project of the European Union’s Horizon 2020 Research and Innovation Program [Grant 848158], the European Commission’s NextGenerationEU through the CSIC Interdisciplinary Thematic Platform (PTI+) NEURO-AGING+ (PTI-NEURO-AGING+) and Severo Ochoa grant of the National Agency for Research (AEI)- Spanish Ministry of Science and Innovation (MCIU) (Ref. CEX2021-001189-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications-2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum

  • Byndloss, Mariana
  • Devkota, Suzanne
  • Duca, Frank
  • Hendrik Niess, Jan
  • Nieuwdorp, Max
  • Orho-Melander, Marju
  • Sanz Herranz, Yolanda
  • Tremaroli, Valentina
  • Zhao, Liping
This article summarizes the state of the science on the role of the gut microbiota (GM) in diabetes from a recent international expert forum organized by Diabetes, Diabetes Care, and Diabetologia, which was held at the European Association for the Study of Diabetes 2023 Annual Meeting in Hamburg, Germany. Forum participants included clinicians and basic scientists who are leading investigators in the field of the intestinal microbiome and metabolism. Their conclusions were as follows: 1) the GM may be involved in the pathophysiology of type 2 diabetes, as microbially produced metabolites associate both positively and negatively with the disease, and mechanistic links of GM functions (e.g., genes for butyrate production) with glucose metabolism have recently emerged through the use of Mendelian randomization in humans; 2) the highly individualized nature of the GM poses a major research obstacle, and large cohorts and a deep-sequencing metagenomic approach are required for robust assessments of associations and causation; 3) because single-time point sampling misses intraindividual GM dynamics, future studies with repeated measures within individuals are needed; and 4) much future research will be required to determine the applicability of this expanding knowledge to diabetes diagnosis and treatment, and novel technologies and improved computational tools will be important to achieve this goal., The 2023 Diabetes, Diabetes Care, and Diabetologia expert forum “The Microbiome and Diabetes: Research, Translation and Clinical Applications,” including a subsequent symposium presented on this topic and the preparation of this article, was supported by a grant from the Novo Nordisk Foundation (NNF23SA0085453). M.B. is a Howard Hughes Medical Institute Freeman Hrabowski Scholar and is supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant NIDDK R01DK131104, the Pew Charitable Trusts (2022-A-19568), and the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease (022792). S.D. is supported by NIDDK grants NIDDK R01DK123446 and 1DP1 DK130687. J.H.N. is supported by Swiss National Science Foundation (SNSF) grant 310030_219210. M.N. is supported by a personal ZONMW-VICI grant 2020 (09150182010020) and a DFN-DON grant 2020 (2020.10.002). Y.S. is supported by grants from the Spanish Ministry of Science, Innovation and Universities MICIU/AEI (PID2020-119536RB-I00) and Severo Ochoa Center of Excellence (Ref. CEX2021-001189-S/10.13039/501100011033). V.T. is a co-principal investigator of a research project funded by the European Union’s Innovative Medicines Initiative (IMI grant 875534)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications-2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum

  • Byndloss, Mariana
  • Devkota, Suzanne
  • Duca, Frank
  • Niess, Jan Hendrik
  • Nieuwdorp, Max
  • Orho-Melander, Marju
  • Sanz Herranz, Yolanda
  • Tremaroli, Valentina
  • Zhao, Liping
This article summarizes the state of the science on the role of the gut microbiota (GM) in diabetes from a recent international expert forum organized by Diabetes, Diabetes Care, and Diabetologia, which was held at the European Association for the Study of Diabetes 2023 Annual Meeting in Hamburg, Germany. Forum participants included clinicians and basic scientists who are leading investigators in the field of the intestinal microbiome and metabolism. Their conclusions were as follows: 1) the GM may be involved in the pathophysiology of type 2 diabetes, as microbially produced metabolites associate both positively and negatively with the disease, and mechanistic links of GM functions (e.g., genes for butyrate production) with glucose metabolism have recently emerged through the use of Mendelian randomization in humans; 2) the highly individualized nature of the GM poses a major research obstacle, and large cohorts and a deep-sequencing metagenomic approach are required for robust assessments of associations and causation; 3) because single-time point sampling misses intraindividual GM dynamics, future studies with repeated measures within individuals are needed; and 4) much future research will be required to determine the applicability of this expanding knowledge to diabetes diagnosis and treatment, and novel technologies and improved computational tools will be important to achieve this goal., The 2023 Diabetes, Diabetes Care, and Diabetologia expert forum “The Microbiome and Diabetes: Research, Translation and Clinical Applications,” including a subsequent symposium presented on this topic and the preparation of this article, was supported by a grant from the Novo Nordisk Foundation (NNF23SA0085453). M.B. is a Howard Hughes Medical Institute Freeman Hrabowski Scholar and is supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant NIDDK R01DK131104, the Pew Charitable Trusts (2022-A-19568), and the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease (022792). S.D. is supported by NIDDK grants NIDDK R01DK123446 and 1DP1 DK130687. J.H.N. is supported by Swiss National Science Foundation (SNSF) grant 310030_219210. M.N. is supported by a personal ZONMW-VICI grant 2020 (09150182010020) and a DFN-DON grant 2020 (2020.10.002). Y.S. is supported by grants from the Spanish Ministry of Science, Innovation and Universities MICIU/AEI (PID2020-119536RB-I00) and Severo Ochoa Center of Excellence (Ref. CEX2021-001189-S/10.13039/501100011033). V.T. is a co-principal investigator of a research project funded by the European Union’s Innovative Medicines Initiative (IMI grant 875534)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Emerging alternatives to control fungal contamination

  • Sánchez-Torres, Paloma
One of the main challenges in food research is maintaining the food supply in a sustainable, safe, and nutritious way for an ever-growing population. Fungal contamination affects the productivity and quality of food, leading to its deterioration and great economic losses. Phytopathogenic fungi can destroy up to 30% of agricultural products. The presence of mycotoxin-producing fungi, in addition to damaging food, can further reduce the availability of fresh and safe food. Mycotoxins pose a health risk, constituting a significant threat to the quality and safety of food around the world. The use of synthetic fungicides is used to control fungi and mycotoxins, generating additional concern due to the toxicity of these products. Therefore, it is urgent to propose new control alternatives that help to prevent fungal contamination. This review provides an overview of some alternatives for the development of new, safe, and effective control methods against fungi that affect food safety., Paloma Sánchez-Torres acknowledges the award of the Spanish government MCIU/AEI to the IATA-CSIC as Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIU/AEI/10.13039/501100011033). Paloma Sánchez-Torres acknowledges the help of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The role of coagulase-negative staphylococci on aroma generation of fermented sausage

  • Chen, Juan
  • Li, Shenmiao
  • Lin, Yaqiu
  • Toldrá, Fidel
  • Lu, Xiaonan
Fermented sausages are popular meat products with many different varieties. The aroma of fermented sausages depends on the metabolic activities of microbiota, mainly involving lactic acid bacteria and catalase-positive cocci, the group of coagulase-negative staphylococci (CNS) in particular. Regarding staphylococci, this work elucidated their generation of aroma precursors from hydrolase, metabolic activities contributing to aroma development, antioxidant effects that improve aroma via preventing excessive lipid oxidation. The metabolic pathways of staphylococci that play a role in aroma formation involve carbohydrate fermentation, amino acid degradation, fatty acid β-oxidation, and esterase activities. Their antioxidant activities are associated with superoxidase dismutase and catalase activities, as well as the production of antioxidant peptides. Processing conditions may influence CNS communities and affect aroma characteristics of fermented sausages. Implementation of genome sequencing and editing to select and customize CNS with specific biosynthetic metabolic pathways was proposed forward, offering a great potential for enhancing aroma development during sausage fermentation., This work was supported by the Scientific and Technological Innovation Team for Qinghai-Tibetan Plateau Research in Southwest Minzu University (2024CXTD12), The Sichuan Science and Technology Program (2022JDTD0030), McGill University, and Spanish MCIN/AEI/10.13039/501100011033 for Center of Excellence Severo Ochoa CEX2021–001189-S., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021–001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Aroma of Non-Fermented and Fermented Dry-Cured Meat Products: Savory and Toasted Odors

  • Li, Lei
  • Belloch, Carmela
  • Flores Llovera, Mónica
Volatile chemicals containing nitrogen and sulfur as key odors in dry-cured meat products have extremely low odor thresholds. These compounds play an important part in the overall uniqueness and characteristic flavor of dry-cured meat products, contributing to savory and toasted aroma sensations, respectively. In this review, we define the different volatiles and aroma compounds related to the flavor of dry-cured meat products. Moreover, the main differences regarding volatiles, aromas, and flavor profiles from non-fermented and fermented dry-cured meat products are summarized. Comparisons using the same volatile extraction techniques revealed that dry loins contained the most sulfur- and nitrogen-containing compounds, while complex flavor and aroma compounds in fermented sausages were greatly impacted by the fermentation process. The screening and quantification of savory and toasted odors showed that methionol, dimethyl sulfide, and 2-methyl-3-(methylthio)furan were mainly reported in non-fermented products, whereas pyrazines were mainly detected in fermented meat products. Finally, the different mechanisms in the generation of savory and toasted aromas, including chemical reactions and biochemical reactions by microorganisms (bacteria, yeast, and molds), are discussed. These discussions will help to better understand the complex flavor of dry-cured meat products., This review is supported by MCIU/AEI/10.13039/501100011033 (Grants PID2021-122581OB-100 and to IATA-CSIC as Center of Excellence Severo Ochoa CEX2021-001189-S) from Spain and by “ERDF A way of making Europe”., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventions

  • Flores Ventura, Eduard
  • Lane, Jonathan A.
  • Turjeman, Sondra
  • Vidra, Nikoletta
  • Weiss, Gisela Adrienne
  • Gross, Gabriele
  • Chang, Ching Yu
  • Koren, Omry
Pregnancy induces notable alterations in the gut, vaginal, and oral microbiota driven by hormonal, immune, metabolic, dietary, and environmental factors. During pregnancy, the gut microbiota is characterized by increased proportions of the genus Bifidobacterium and the phyla Pseudomonadota (formerly Proteobacteria) and Actinomycetota (formerly Actinobacteria). These changes occur alongside reduced alpha diversity and greater beta diversity, changes that influence maternal metabolism and fetal development. Shifts in gut and oral microbiota have been associated with complications such as preterm birth (PTB), pre-eclampsia, and gestational diabetes (GDM), though patterns are sometimes inconsistent. The vaginal microbiota remains Lactobacillus-dominant during pregnancy, with reduced diversity leading to reduced risk of pathogenic infection and increased diversity has been linked with a higher risk of PTB. Hormonal changes also affect the oral microbiota, potentially increasing pathogenic species and contributing to adverse outcomes like PTB. Probiotic supplementation during pregnancy has significant potential to reduce adverse pregnancy outcomes; however, clinical studies are still limited. Probiotics may be effective in alleviating maternal constipation and lead to lower PTB risk, particularly by modulating the vaginal microbiota, but they have limited impact on GDM. In the context of maternal mental health, some studies suggest benefits of probiotics in reducing anxiety, but effects on depression are inconclusive. This perspective examines how pregnancy-related microbial shifts, both natural and probiotic-induced, affect maternal and fetal health and highlights potential opportunities for the innovative use of probiotics during the gestation period., E.F.V thanks to a Predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for the training of doctors within the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023. [ref. CEX2021-001189-S-20-1]. E.F.V, S.T., and O.K. are supported by a Biostime Institute Nutrition & Care (BINC) research grant., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hydrocolloid-based coatings applied on biobased/biodegradable food flexible packaging, A review. Part 1 - Biopolymer to coat and available technologies

  • Debeaufort, Frédéric
  • Kurek, Mia
  • Fabra, María José
  • Ghasemi, Yasaman
  • Ščetar, Mario
  • Galić, Kata
  • Benbettaieb, Nasreddine
The shift towards sustainable food packaging has intensified research into hydrocolloid-based coatings applied to biobased and biodegradable flexible films. Indeed, most of the biobased and/or biodegradable film available for the food market exhibits too low properties, but that could be compensated by coating applications. This review explores the potential of hydrocolloids as coating materials to improve the functional properties of sustainable flexible packaging such as polylactides, polyhydroxyalkanoates, thermoplastic starch, polycaprolactone. Hydrocolloid-based coatings, including proteins, polysaccharides, and their composites, are particularly promising due to their ability to improve barrier, surface and mechanical performance while maintaining biodegradability and food safety. The choice of technique for coating application depends on the desired coating thickness, adhesion strength, and functional enhancements. Various coating technologies are discussed, ranging from solvent-free (dry) processes, such as extrusion-lamination and hot press techniques, to wet-based (solvent) methods, including solution casting, spray coating, electrospinning, etc. Surface treatments, such as plasma activation, are often required before coating application to enhance adhesion, wettability, and mechanical resistance. This review provides an in-depth analysis of available biodegradable polymer films suitable for coating and food applications and the coating technologies, setting the foundation for the development of next-generation eco-friendly packaging films., For all partners, this work was supported by the EVOLVEPACK project, a PRIMA-Horizon 2020. For the University of Zagreb (authors Kurek, Ščetar, Galić), the EVOLVEPACK Grant is PCI2024-153409, work is also supported by the Croatian Ministry of Science, Education and Youth. For the IATA (author Fabra), the EVOLVEPACK Grant is Grant PCI2024-153409, funded by MICIU/AEI/10.13039/501100011033 and, by ERDF A way of making Europe. The Accreditation asCenter of Excellence Severo Ochoa CEX2021-001189-S funded by MCIU/AEI/10.13039/501100011033 is also fully acknowledged. For the university of Burgundy Europe (authors Debeaufort, Benbettaieb and Ghasemi), the EVOLVEPACK grant is PCI2024-153409 and is also funded by the National Agency for research (ANR), referenced ANR-24-P013-0008-04, and contributes also to NanoBap project grant n° ANR-23-CE09-0003-02., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unlocking the power of human milk and infant feeding: Understanding how nutrition and early microbiota interaction shapes health programming

  • Zhernakova, Alexandra
  • Yassour, Moran
  • Hall, Lindsay J
  • Collado, María Carmen
Human milk represents a highly evolved bioactive system that promotes colonization by infant microbial pioneers, supports immune maturation, and fosters infant development. Beyond providing nutrition, human milk contains key bioactive components, such as microbes, metabolites, human milk oligosaccharides, immunoglobulins, lactoferrin, and antimicrobial peptides. These factors influence colonization of the infant gut microbiome and facilitate immune development and metabolic health, with implications for health outcomes and risk of non-communicable diseases. In this review, we highlight the impact of infant feeding, human milk constituents (especially bioactive compounds), and weaning on infant microbial trajectories. By understanding how early-life nutrition influences microbial colonization and nutrient sensing, i.e., "how we feed our microbes," we can develop targeted interventions and personalized diets to support proper gut maturation and disease prevention from infancy to adulthood, as well as explore the therapeutic potential of human milk bioactives beyond infancy, offering new strategies for disease prevention and treatment., M.C.C. acknowledges support from a H2020-ERC Starting Grant (MAMI-639226 project), the Horizon Europe Program (INITIALISE-101094099 project), a Spanish Ministry of Science and Innovation (MCIN) research grant (MAMI+, ref. PID2022-139475OB-I00), and PROMETEO/GVA (Microglocal ref. CIPROM2023/030). M.C.C. would like to acknowledge the award of the Spanish Government MCIN/AEI to the IATA-CSIC as Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). L.J.H. is supported by a Wellcome Trust Investigator Award (220876/Z/20/Z) and the Biotechnology and Biological Sciences Research Council Institute Strategic Programme Food, Microbiome and Health BB/X011054/1 and its constituent project BBS/E/QU/230001B. A.Z. is supported by Netherlands Organization for Scientific Research (NWO) VICI grant VI.C.232.074, NWO Gravitation grant ExposomeNL 024.004.017, NWO KIC grant KICH1.LWV04.21.01, ZonMW ME/CFS grant 10091012110015, the EU Horizon Europe Program grants INITIALISE (101094099), and DarkMatter (“ID-DarkMatter-NCD” [project number 101136582])., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Are conventional antidepressants enough? The gut microbiome and nanocarrier-based delivery systems as future prospects for depression treatment

  • Gastaldo Jordán, Isis
  • Villalba Pita, Claudia
  • Martínez-Raga, José
  • Sanz, Yolanda
  • Medina Rodríguez, Eva M.
Depression is the leading cause of disability worldwide and thus a major contributor to the economic burden of disease. In addition to genetic and epigenetic factors, sustained psychological stress linked to modern lifestyles (often characterized by high social expectations, elevated workload and increasing financial needs) may trigger psychiatric diseases such as depression. The effective treatment of this psychiatric condition represents one of the major challenges of our time, due to its skyrocketing increase in prevalence. While conventional antidepressants often provide low response rates and have frequent adverse effects, emerging research is revealing novel and more efficient therapeutic approaches. Notably, the bacteria that populates our intestinal tract, also known as the gut microbiota, is highly susceptible to stress and other factors associated with depression. Therefore, gut microbiota-targeting interventions based on lifestyle modifications or direct supplementation with biotherapeutic agents are being proposed as monotherapy or as adjuvants to conventional treatments. In addition, novel delivery systems, such as nanocarriers, for current antidepressants are being explored to improve drug bioavailability and therapeutic efficiency. This review summarizes the role of the gut microbiota in the pathogenesis of depression and its link with current antidepressant treatments. Furthermore, it explores how strategies like nanoparticle-based delivery systems are paving the way for the next generation of treatments., This work was funded by the Miguel Servet program from Carlos III Health Institute (ISCIII; CP22/00030), and the State Research Agency (AEI; PID2022–142106OA-I00), co-funded by the European Union, the AGROALNEXT program, supported by the Spanish Ministry of Science, Innovation and Universities (MCIU) with funding from European Union NextGenerationEU (PRTR-C17.I1) and Generalitat Valenciana (GVA) (AGROALNEXT/2022/049), and the award to IATA-CSIC as an Accredited Research Center of Excellence “Severo Ocha” (CEX2021–001189-S/MCIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The gut microbiome connects nutrition and human health

  • Sanz Herranz, Yolanda
  • Cryan, John F.
  • Deschasaux-Tanguy, Mélanie
  • Elinav, Eran
  • Lambrecht, Rebekka
  • Veiga, Patrick
The gut microbiome has an undeniable role in mediating the health effects of the diet, given its ability to co-digest nutrients and influence nutrient signalling to multiple organ systems. As a suboptimal diet is a major risk factor for and contributor to disease, understanding the multidirectional interactions between the food we eat, the gut microbiome and the different body organ systems is crucial from a public health perspective. Indeed, this research area is leading to the refinement of nutritional concepts and strategies to optimize health through diet. In this Review, we provide an update on how dietary patterns and food intake shape gut microbiome features, the mode of action of diet-microorganism interactions on the immune, nervous and cardiometabolic systems and how this knowledge could explain the heterogeneity of dietary responses, and support food-based dietary guidelines and medical and precision nutrition. Finally, we discuss the knowledge gaps and research efforts needed to progress towards the integration of microbiome science with more precise dietary advice to leverage the role of nutrition in human health., The work of Y.S. is funded by the Spanish Ministry of Science, Innovation and Universities (grant PID2023-150693OB-I00), and a “Severo Ochoa” grant of the National Agency for Research (AEI)–Spanish Ministry of Science and Innovation (ref. CEX2021-001189-S). The work of P.V. is funded in part by a Metagenopolis grant (ANR-11-DPBS-0001) and the PEPR-SAMS Cohortes-Microbiomes Project (ANR-24-PESA-0005). J.F.C. is supported by Science Foundation Ireland (SFI/12/RC/2273_P2), Saks Kavanaugh Foundation and Swiss National Science Foundation (CRSII5_186346/NMS2068). E.E. is supported by the European Union Thrive and Nutriome Consortiums and is a partner, Novo Nordisk Foundation Microbiome Health Initiative (MHI). R.L. is grateful to the Azrieli Foundation for an Azrieli Fellowship., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Food spoilage and packaging solutions: key Mediterranean case studies

  • de Chiara, Maria Lucia Valeria
  • Essid, Ines
  • Daaloul, Olfa
  • Mallek, Hana
  • Guillard, Valérie
  • Coffigniez, Fanny
  • Hariri, Mina
  • Lammi, Sarah
  • Kurek, Mia
  • Awad, Nour M.H.
  • Abushady, Asmaa M.
  • Locali-Pereira, Adilson R.
  • Ribeiro, Nadia
  • Pereira, Cristina Silva
  • Goksen, Gulden
  • Olivares, Marta
  • Capozzi, Vittorio
The Mediterranean agri-food sector represents a model of millennial evolution, with a deep connection to lifestyle and a unique biodiversity of edible resources, renowned for its ability to combine well-being, health, and resilience. This reference, in terms of production and consumption, is currently facing growing challenges: evolving lifestyles, global economic changes, pollution, climate change, and resource scarcity. In this context, the sustainable transition of food systems represents a priority to facilitate change, ensuring producers and consumers can adhere to a dietary and lifestyle pattern traditionally observed in countries bordering the Mediterranean Sea ('Mediterranean' style). This review examines the diversity of food production, the complexity of spoilage mechanisms, and the evolution of packaging strategies to identify critical case studies in the Mediterranean region, advancing frontier research in packaging technology and supporting the development of innovative, waste-reducing solutions. In this review article, five food categories (fruit and vegetables, seafood, dairy, bread, and meat) were selected based on their relevance to Mediterranean systems and the diversity of issues, providing a comparative insight into spoilage mechanisms and storage requirements. The selection of a limited number of representative food case studies is essential to ensure consistency, reproducibility, and interdisciplinary collaboration, especially in a complex context like the Mediterranean. This review encourages collaborative and interdisciplinary research and a positive interaction among sustainable packaging innovation, the valorisation of microbial resources, and targeted spoilage management. These strategies are crucial to reducing food waste & loss, supporting the principles of a circular economy, and preserving the potential of Mediterranean agri-food production and consumption systems., This work was supported by the “INTelligent, ACTive MicroBIOme-based, biodegradable PACKaging for Mediterranean food”, INTACTBIOPACK project (Section 2 Call, Multi-topic 2023), funded by the Partnership for Research and Innovation in the Mediterranean Area (PRIMA), supported by the European Union H2020 programme. For Mia Kurek, University of Zagreb, the INTACTBioPack Grant work is also supported by the Croatian Ministry of Science, Education and Youth. Nour M. H. Awad and Gulden Goksen thank to Scientific and Technological Research Council of Turkey (TUBITAK) under the Grant Number 124N037 for its support., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Programming the Infant Gut: How Maternal and Early Life Nutrition Shape the Infant Microbiome and Long-term Health-A Narrative Review

  • Fontaine, Fanette
  • Turjeman, Sondra
  • Haib, Meriam
  • Collado, María Carmen
  • Callens, Karel
  • Koren, Omry
Childhood malnutrition, including undernutrition, obesity, and micronutrient deficiencies, remains a major global health burden. Emerging evidence points to the gut microbiome as a critical mediator linking maternal, prenatal, and early-life nutrition to long-term offspring health outcomes. From conception and through the first years of life, maternal diet, metabolic state, and environmental exposures shape offspring microbial colonization and maturation. Breastfeeding and consumption of fiber-rich and fermented foods (maternal and post-weaning) support beneficial microbiota, while high-fat, high-sugar diets, xenobiotics, and artificial additives may promote dysbiosis. The composition and diversity of the infant microbiome influence immune, metabolic, and neurodevelopmental processes and may also contribute to the intergenerational transmission of malnutrition. While commercial formulas increasingly include "biotics" to mimic human milk, exclusive breastfeeding remains the gold standard. Complementary feeding practices, including timing and diet quality, are known to modulate microbial maturation. Diet-based interventions in pregnancy show promise in improving microbiome function and preventing disease in offspring. Because the microbiome is highly plastic in the first years of life, this window offers unique opportunities for preventive strategies targeting maternal and child nutrition. Integrating microbiome science into public health and dietary guidelines could enhance current approaches to breaking the cycle of malnutrition and promoting lifelong health., M.C.C. acknowledges support from the H2020-ERC Starting Grant (MAMI-639226 project), the Spanish Ministry of Science and Innovation (MCIN) research grant (MAMI Plus-PID2022-139475OB-I00), and also the Severo Ochoa Center of Excellence Accreditation awarded by the Spanish government MCIN/AEI to the IATA-CSIC (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). The work of O.K. and S.T. was supported by grant 1001576036 from the Ministry of Innovation Science and Technology and grants Cure2023007 and SPCL2023007 from The Russell Berrie Galilee Diabetes SPHERE. M.C.C., O.K., and S.T. were also supported by the Biostime Institute for Nutrition & Care (BINC) Foundation., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human Milk Bioactive Compounds and Allergic- and Infectious-Related Infant Outcomes: A Systematic Review

  • Flores Ventura, Eduard
  • Guseva, Daria
  • Hübert, Vanessa
  • Samarra, Anna
  • Ensenauer, Regina
  • Collado, María Carmen
The impact of Human Milk (HM) bioactive compounds on infant health is crucial yet complex. Current research highlights their role in immune system development and disease prevention. This review aims to synthesize existing literature on the role of HM's bioactive compounds in the onset of diagnosed allergies, immunological diseases, and responses to infectious diseases by infants and children up to 18 years. The systematic review adhered to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). A comprehensive search strategy was employed across PubMed, Web of Science, SCOPUS, Scientific Electronic Library Online (SciELO), Cochrane Library, Latin American and Caribbean Health Sciences Literature (LILACS), and LIVIVO. Quality assessment utilized Joanna Briggs Institute checklists for various study designs. Protocol: CRD42023432030. The systematic review encompassed 34 studies, published from 1983 to 2024, representing a total of 9,298 mother-infant dyads. Included studies reported that allergic-related conditions, particularly food allergy, sensitization, and atopic dermatitis, were inversely associated with HM linolenic and linoleic acid. In a meta-analysis of three studies, infants with atopic dermatitis showed lower total omega-3 levels (SMD = -0.46, 95% CI: -1.82 to -0.90, I2 = 91%, p < 0.01), with reduced EPA and DGLA, suggesting, but not confirming, a potential protective role of omega-3 and involvement of inflammatory pathways. Furthermore, results on infectious-related conditions, primarily diarrhoea and Group B Streptococcus (GBS) infections, suggested inverse associations with 2'-fucosyllactose (2´-FL), lacto-N-difucohexaose I (LDFH-I), and immunoglobulins (Anti-GBS secretory immunoglobulin A (SIgA), anti-lipopolysaccharide IgA (Anti-LPS IgA), anti-cholera toxin IgA, respectively). Results of studies on upper and lower respiratory tract infections, otitis media, and dental caries suggested inverse associations with galectins and galectin-3, lacto-N-tetraose (LNT), 2´-FL, and Haemophilus influenzae. Data suggest that HM bioactive compounds, such as polyunsaturated fatty acids (PUFAs), HMOs, and a number of specific immunoglobulin A (IgA) antibodies may influence allergic and infectious outcomes in infants. In pooled analyses of omega-3 levels, HM fed to infants with atopic dermatitis showed reduced EPA and DGLA. However, these pooled estimates are severely limited by high statistical heterogeneity (I2 = 91%) and should be interpreted as exploratory findings. Despite of the limited overall evidence due to heterogeneity, low replication, and methodological variability, this review offers a broad synthesis of current findings and highlights key knowledge gaps, providing a foundation for future research focused on elucidating the immunological roles of understudied components, such as antimicrobial peptides, through multi-omics and longitudinal approaches., E.F.V. was supported by a predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for doctoral training within the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023 (ref. CEX2021-001189-S-20-1). E.F.V. and M.C.C. also acknowledge support from the Spanish Ministry of Science and Innovation (MAMI-Plus project, ref. PID2022-139475OB-I00), as well as from the Joint Action, “European Joint Programming Initiative: A Healthy Diet for a Healthy Life” (JPI-HDHL) FOOD-HYPERSENS call (ECOBIOTIC project, ref. MCIN/AEI/10.13039/501100011033 and the European Union ‘NextGenerationEU’/PRTR), and national funding from the Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A) of the Spanish Ministry of Science, Innovation and Universities. The IATA-CSIC team acknowledges the award from the Spanish Government (MCIN/AEI) to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as a Centre of Excellence Severo Ochoa (CEX2021-001189-S, MCIN/AEI/10.13039/501100011033), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lycopene in citrus fruit: biochemical mechanisms, molecular insights and health implications

  • Zacarías-García, Jaime
  • Karp, David
  • Roberts, Jon
  • Tornero Raga, Carlos
  • Zacarías, Lorenzo
  • Rodrigo, María Jesús
Accumulation of the carotene lycopene in Citrus is an unusual trait found in a limited number of pummelos, grapefruits, oranges, lemons and related hybrids, imparting a distinctive pink-to-red color to the fruit. This phenotype most often arises from spontaneous bud-sport mutations and is generally confined to the inner fruit tissues (endocarp), although in some cultivars lycopene is also found in the rind (flavedo) or albedo. Pink-fleshed cultivars typically show an altered carotenoid profile, particularly in the pulp, with higher total carotenoid levels than their parental or standard counterparts. Comparative analyses across citrus species and cultivars reveal both shared and distinct patterns in carotenoid accumulation and tissue-specific pigmentation. The genetic and molecular bases of these changes are not yet fully resolved and appear to differ among species and cultivars. Beyond their scientific interest, these cultivars present promising opportunities for commercial development due to their striking coloration and provide enhanced nutritional value because of their high carotenoid levels. This review integrates and compares evidence from multiple citrus species and cultivars on the origin and diversity of lycopene-accumulating Citrus, their characteristic carotenoid composition, the proposed molecular and biochemical mechanisms leading to lycopene accumulation, and the nutritional and health implications of pink-fleshed cultivars., This work was supported by the Generalitat Valenciana under Grant PROMETEO/2020/027; the Consejo Superior de Investigaciones Científicas (CSIC) under Grant 202370E064; and the Conselleria d’Innovació, Universitats, Ciència i Societat Digital under Grant CIAPOT/2023/026. Jaime Zacarías-García, Lorenzo Zacarías and María Jesús Rodrigo are members of the Spanish Carotenoid Network (CaRed) supported by the Spanish Government (MCIN/AEI/10.13039/501100011033) under Grant RED2022-134577-T. The authors acknowledge the award granted to IATA-CSIC as a Severo Ochoa Center of Excellence (CEX2021-001189-S, MICIU/AEI/10.13039/501100011033) and the IMPULSA 2024 project funded by the same Severo Ochoa program., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Off to a good start: current gaps and priorities in early-life microbiome research

  • Pettersen, Veronika Kuchařová
  • Ponsero, Alise Jany
  • Jian, Ching
  • Riumin, Alona
  • Kurilshikov, Alexander
  • Moyo, Sabrina John
  • Justine, Museveni
  • Klingenberg, Claus
  • Debelius, Justine
  • Valles-Colomer, Mireia
  • Noordzij, Hanna Theodora
  • Zhernakova, Alexandra
  • Korpela, Katri
  • Esteban Torres, María
  • Brusselaers, Nele
Early-life microbial exposures are essential for optimal development of human physiology. Yet, understanding of the human microbiome during pregnancy and childhood is still far from being complete. To identify knowledge gaps and establish research priorities, a multidisciplinary expert panel used the Delphi method for consensus development and conducted a literature search on early-life microbiome determinants. Responses from 55 researchers from an online survey were analyzed alongside keyword frequency from 20 501 publications. This approach enabled us to categorize existing evidence and highlight areas requiring investigation. While the main routes for mother-to-child bacterial transmission and their contributions to the newborn microbiome have been studied, many gaps remain. Priority areas include non-bacterial microbes, ecological principles of colonization, environmental and social influences, body sites beyond the gut, and factors affecting the maternal microbiome and its effects on the child's microbiome. Significance of factors such as hygiene habits, non-antibiotic medications, and pollution remains to be uncovered. Knowledge is also limited on postnatal microbial sharing via household contacts and shared environments (e.g. family members, peers) and the contribution of these pathways to microbiome assembly. We hope this report will guide and inspire future research into the early-life microbiome as a modifiable factor in reducing disease risk., This project was possible through a grant awarded to V.K.P. by the Center for Advanced Study (CAS) in Oslo, Norway, which funded and hosted the Young CAS research project (Infant Gut Microbiome Acquisition: Off to a Healthy Start) during the 2022/23 academic year. CAS is an independent research foundation funded by the Norwegian Ministry of Education and Research. M.V.-C. acknowledges funding from the Spanish Ministry of Science and Innovation (Knowledge Generation Project PID2022-139328OA-I00), the Spanish Ministry of Universities (Beatriz Galindo Junior fellowship BG22/00172), and from La Caixa Foundation (Junior Leader fellowship 100010434, code LCF/BQ/PI24/12040001). M.E.T. acknowledges funding from the European Union’s Horizon 2020 Marie Skłodowska-Curie Actions postdoctoral fellowship (MicroMi-898088) and the Ramón y Cajal grant (RYC2023-045839-I) from the Ministry of Science, Innovation and Universities, the State Research Agency MCIU/AEI/10.13039/501100011033 and the FSE+. The Institute of Agrochemistry and Food Technology (IATA-CSIC) is a Center of Excellence Severo Ochoa (CEX2021- 001189-S MCIN/AEI/10.13039/501100011033). A.Z. is supported by the Netherlands Organization for Scientific Research NWO-VICI grant VI.C.232.074, the NWO Gravitation grant Exposome-NL(024.004.017), and the NWO KIC grant KICH1.LWV04.21.01, the ZonMW ME/CFS grant 10091012110015, European Union’s Horizon Europe Program grant INITIALIZE (101094099), and European Union’s Horizon Europe Program grant DarkMatter (ID-DarkMatter-NCD, 101136582). A.J.P. acknowledges support from the Academy of Finland (339172) and from the BBSRC Institute Strategic Program Food Microbiome and Health BB/X011054/1 and the BBSRC Core Capability Grant BB/CCG2260/1. H.T.N. was supported by the Research Council of Norway (grant #300948), and N.B. by the Swedish Research Council (2023–02868)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota and immunometabolism in obesity

  • Torres Mayo, Alba
  • Liébana García, Rebeca
  • Olivares, Marta
  • Pellón, Aize
  • Anguita, Juan
  • Sanz Herranz, Yolanda
The gut microbiota plays a central role in modulating both immunity and metabolism. Obesity-associated microbiota configuration is a critical driver of persistent inflammatory activation and immune dysfunction, ultimately leading to chronic metabolic disorders. Immunometabolism examines how metabolic demands shape immune cell function and how immune responses influence cellular metabolism. Emerging research on how the gut microbiota contribute to immune cell metabolic processes and the resulting health outcomes is deepening our understanding of the mechanisms underlying obesity and metabolic diseases. In this review, we summarize how intracellular metabolic pathways and master regulators, such as mTOR and AMPK, orchestrate immune cell function and how their dysregulation contributes to obesity-associated immune and metabolic dysfunction. We also discuss how gut microbiota influences the immunometabolism of different myeloid and lymphoid cell subsets and intestinal epithelial cells. Finally, we review the role of microbially produced metabolites, including short-chain fatty acids, lactate, succinate, bile acids, and amino acids, in reprogramming immune cell metabolism. We also discuss whether modulating gut microbiota function to regulate immunometabolic pathways could help restore immune homeostasis and reduce obesity-related complications., This study has been funded by the Spanish Ministry of Science, Innovation and Universities (MCIU; grant PID2023-150693OB-I00 to YS, PID2024-155763OB-I00 to JA), and the “Severo Ochoa” grant of the National Agency for Research (AEI)- MCIU (Ref. CEX2021-001189-S to IATA-CSIC, CEX2021-001136-S to CIC bioGUNE). The predoctoral contract to A. T-M from MCIU is acknowledged. AP is supported by an MSCA Postdoctoral Fellowship (award number 101150747)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S and CEX2021-001136-S)., Peer reviewed